TOMMASI, MARIASILVIA
TOMMASI, MARIASILVIA
FISIOPATOLOGIA CLINICA (attivo dal 01/08/1980 al 31/12/2012)
A controversial problem: is there a relationship between parathyroid hormone level and parathyroid size in primary hyperparathyroidism?
1997 F. Locchi; M. Tommasi; M. L. Brandi; F. Tonelli; U. Meldolesi
Assessment of Phosphohexose-isomerase, Beta2-microgubulin and Ferritin in lung cancer
1984 B. Neri; T. Comparini; G. Torcia; M. Tommasi; S. Bacalli; A. Ciapini
Beta2-microglobulina, marker tumorale nel mieloma multiplo
1981 B. Neri; E. Spitali; T. Comparini; G. Guidi; M. Tommasi
Bio-markers in the detection of myeloproliferactive diseases : a combined study on Phosphohexose isomerase Beta2-microglobulin ad Ferritin
1983 B. Neri; T. Comparini; S. Guidi; M. Tommasi
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients
2020 Malapelle U.; Rossi G.; Pisapia P.; Barberis M.; Buttitta F.; Castiglione F.; Cecere F.L.; Grimaldi A.M.; Iaccarino A.; Marchetti A.; Massi D.; Medicina D.; Mele F.; Minari R.; Orlando E.; Pagni F.; Palmieri G.; Righi L.; Russo A.; Tommasi S.; Vermi W.; Troncone G.
Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma
2006 GALLI G; ZONEFRATI R; GOZZINI A; MAVILIA C; MARTINETI V; TOGNARINI I; NESI G; MARCUCCI T; TONELLI F; TOMMASI M; RAGGI CC; PINZANI P; M.L. BRANDI
CLINICAL UTILITY OF COMBINED USE OF PLURIME TUMOR MARKERS IN HUMAN BREAST CANCER
1989 B. NERI; BARTALUCCI S.; CATALIOTTI L.; DISTANTE V.; TOMMASI M.; CIAPINI A.
COMPARAISON OF THE USEFULNESS OF DOPPLER-DERIVED DECELERATION TIME VERSUS PLASMA BRAIN NATRIURETIC PEPTIDE TO PREDICT LEFT VENTRICULAR REMODELING AFTER MECHANICAL REVASCULARIZATION IN PATIENTS WITH ST--ELEVATION ACUTE MYOCARDIAL INFARCTION AND LEFT VENTRICULAR SISTOLIC DYSFUNCTION
2005 V. BODDI; M. TOMMASI; S. RASPANTI; G. PARODI; G. CERISANO; P. PUCCI; R. VALENTI; D. ANTONIUCCI;
Creatine Kinase isoenzyme BB : a lung cancer associated marker
1987 B. Neri; S. Bartalucci; M. Gemelli; M. Tommasi; S. Bacalli
Critical analysis of intact PTH monitoring during parathyroid surgery
1997 M. Tommasi; F. Locchi; A. Brocchi; A. Benucci; M.L. Brandi; S. Spini; F. Tonelli; U. Meldolesi
Effects of melatonin administration in patients with advanced solid tumors
1995 B. Neri; A. Brocchi; AM. Carossino; G. Cini-Neri; MT. Gemelli; M. Tommasi; M. Cagnoni
Effects of Melatonin administration on cytochine production in patients with advanced solid tumors
1995 NERI B.; BROCCHI A.; CAROSSINO A.M.; CINI NERI G.; GEMELLI M.T.; TOMMASI M.S.; CAGNONI M.
Esperienza preliminare del nuovo dosaggio "whole PTH" nel monitoraggio intraoperatorio per iperparatiroidismo primario
2001 M. Tommasi; A. Brocchi; S. Raspanti; S. Detti; F. Locchi; G. Fratini; F. Tonelli
Evaluation of reference values for chromogranin A, pancreatic peptide and somatostatin
1998 M. Tommasi; A. Brocchi; S. Raspanti; M.L. Brandi; F. Locchi; U. Meldolesi
FERRITIN AS CHRONOBIOLOGICAL MARKER IN IMMUNOPROLIFERATIVE DISEASE
1983 B. NERI; COMPARINI T.; GUIDI S.; PIERI A.; TOMMASI M.
Intact PTH vs. the whole PTH assay in uremic samples
2001 M. Tommasi; A. Brocchi; S. Raspanti; S. Detti; F. Locchi; S. Bandini
Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism.
2000 F. Tonelli; S. Spini; M. Tommasi; G. Gabbrielli; A. Amorosi; A. Brocchi; M. L. Brandi
Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?
2007 F.Tonelli; T. Marcucci; G. Fratini; M. S. Tommasi; A. Falchetti; M.L. Brandi
Kinetics Analysis of Parathyroid Hormone During Parathyroidectomy in the Assessment of Curative Surgery
2003 M. Tommasi; F. Locchi; M.L. Brandi; A. Brocchi; S. Raspanti; R. Panconesi; F. Tonelli
Model of iPTH clearance after parathyroid adenomectomy
1998 F. Locchi; M. Tommasi; M.L. Brandi; F. Tonelli; U. Meldolesi